M&ABusinessLine
AstraZeneca Pharma India inks agreement with Strand Life Sciences to explore healthcare collaboration
Positive+33
GreyOak summary
AstraZeneca Pharma India Ltd signed a letter of intent with Strand Life Sciences Pvt Ltd to explore healthcare collaboration opportunities in India. Strand Life Sciences is a genomics research and diagnostics company and a subsidiary of Reliance Industries Ltd. The company clarified that this is not a related party transaction.
What it affects
- AstraZeneca Pharma IndiaASTRAZENPositive +33
Signed LoI to explore healthcare collaboration.Rolling sentiment Positive +37
- HealthcarePositive +33
Collaboration opportunities being explored.Rolling sentiment Positive +37
Source
Read the original at BusinessLineMore AstraZeneca Pharma India news
- AstraZeneca Pharma India partners with Reliance Industries’ subsidiary Strand Life SciencesFinancial Express · M&A ·
- AstraZeneca India signs LoI with Reliance's StrandCNBC-TV18 · M&A ·